If you do not meet the reimbursement conditions, you cannot be reimbursed.
According to Baidu Encyclopedia, abeciclib does not meet the reimbursement conditions and cannot be reimbursed. Reimbursement of abeciclib must be met for patients who are ER or PR positive, HER2 is not amplified, and stage 3 or 4.
Abbeciclib, also known as bomacillin, is a targeted drug targeting cyclin-dependent kinases 4 and 6 and is mainly used for the treatment of breast cancer.